Psychosomatic Medicine Faster Service from Outside North America
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lustman, P. J.
Right arrow Articles by Freedland, K. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lustman, P. J.
Right arrow Articles by Freedland, K. E.
Related Collections
Right arrow Endocrinology
Right arrow Depression
Right arrow Diabetes
Psychosomatic Medicine 67:195-199 (2005)
© 2005 American Psychosomatic Society

ORIGINAL ARTICLES

Depression-Related Hyperglycemia in Type 1 Diabetes: A Mediational Approach

Patrick J. Lustman, PhD, Ray E. Clouse, MD, Paul S. Ciechanowski, MD, Irl B. Hirsch, MD and Kenneth E. Freedland, PhD

From the Departments of Psychiatry (P.J.L., R.E.C., K.E.F.) and Medicine (R.E.C.), Washington University School of Medicine, St. Louis, MO; the Department of Veterans Affairs Medical Center (P.J.L.), St. Louis, MO; and the Departments of Psychiatry and Behavioral Sciences (P.S.C.) and Medicine (I.B.H.), University of Washington, Seattle, WA.

Address correspondence and reprint requests to Patrick J. Lustman, PhD, Department of Psychiatry, Washington University School of Medicine, 660 South Euclid Avenue, Campus Box 8134, St. Louis, MO 63110. E-mail: lustmanp{at}wustl.edu


   ABSTRACT
TOP
 ABSTRACT
INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 NOTES
 REFERENCES
 
Objective: Depression is linked with hyperglycemia and with an increased risk for diabetes complications, but the mechanisms underlying these relationships have not been established. In this study, we applied mediational analysis methods to determine whether the hyperglycemic effect of depression could be mediated by poor diabetes self-care.

Methods: Depression symptoms and diabetes self-care activity were assessed in a primary care sample of 188 patients with type 1 diabetes by using the Hopkins Symptom Checklist-90 (SCL-90) and the Summary of Diabetes Self-Care Activities (SDSCA). A composite score of self-care activity was formed from SDSCA ratings for diet amount, exercise, and glucose testing. Degree of hyperglycemia (level of glycosylated hemoglobin [HbA1c]), weight, insulin dose, and other clinical characteristics were obtained from electronic medical records. Ordinary least-squares regression was used to determine the effect of depression on HbA1c level controlling for weight and insulin dose. The SDSCA score was then added to the regression model to determine whether it attenuated the effect of depression symptoms on HbA1c level, thus providing suggestive evidence of mediation from these cross-sectional data.

Results: Depression symptoms, poor diabetes self-care, and hyperglycemia were correlated with one another in univariate analyses (p <.05). Depression symptoms were associated with higher HbA1c after controlling for weight and insulin dose (parameter estimate for depression 0.53, t = 3.6, p <.001). Inclusion of SDSCA in the model minimally attenuated the effect of depression symptoms (adjusted parameter estimate for depression 0.50, t = 3.3, p = .001).

Conclusions: These findings do not support mediation of the depression–hyperglycemia relationship by diabetes self-care behavior. Other pathways, including psychophysiological mechanisms, should be investigated.

Key Words: depression • diabetes mellitus • insulin resistance

Abbreviations: SCL-90 = Hopkins Symptom Checklist-90; SDSCA = Summary of Diabetes Self-Care Activities; HbA1c = glycosylated hemoglobin; CHD = coronary heart disease; BMI = body mass index; ANCOVA = analysis of covariance; SEM = standard error of mean.


   INTRODUCTION
TOP
 ABSTRACT
 INTRODUCTION
METHODS
 RESULTS
 DISCUSSION
 NOTES
 REFERENCES
 
Recent meta-analyses of cross-sectional studies provide evidence that depression in persons with type 1 or type 2 diabetes is linked both with hyperglycemia and with increased risk for diabetes complications such as coronary heart disease (CHD), the principal cause of morbidity and mortality in this population (1–4). Prospective evidence that depression may causally contribute to the development of CHD in diabetic patients also is beginning to appear (3,4). In a 10-year follow-up study of women undergoing scheduled annual diabetes evaluations while participating in a diabetes registry, Clouse et al. (3) found that depression at index evaluation predicted accelerated onset (p <.01) and increased risk for incident CHD, the effect remaining significant after controlling for other risk factors, including age, smoking, and body mass index (age-adjusted hazard ratio = 5.2, 95% confidence interval = 1.4–18.9, p = .01).

The mechanisms by which depression worsens the course of established diabetes are unclear, but its relationship with hyperglycemia is a likely contender. Depression adversely affects a number of behaviors that could interfere with diabetes self-care such as dietary management, physical activity, and adherence to medical treatment (3). Consequently, poor adherence to diabetes self-care is thought to be a primary explanation for depression-related hyperglycemia and previously has been shown to mediate the effects of stress on metabolic control in type 1 diabetes (5). However, the relationship between depression and hyperglycemia, a relationship sustained over long periods of time (6), may be independent of fluctuations in stress; other physiological processes may be in play. Nevertheless, diabetes self-care behavior remains one of the most plausible mediators of depression’s effects on diabetes. Clarifying the role of self-care in the chain of events that link depression with hyperglycemia and poor diabetes outcomes may help guide the design of interventions.

The purpose of the present study was to use mediational analysis methods to investigate the role of diabetes self-care behaviors in depression-associated hyperglycemia. Diabetes self-care was measured using the validated Summary of Diabetes Self-Care Activities (7,8). Patients with type 1 diabetes were chosen so that we could more precisely evaluate glycemic level in relationship to weight and diabetes treatment (insulin dose) while limiting the effect of intrinsic insulin availability, a prominent variable in type 2 diabetic populations. Because the data were cross-sectional, positive findings would necessarily be exploratory, and longitudinal studies would be required in which the temporal precedence among the variables would be defined and a true mediation analysis could be performed (9).


   METHODS
TOP
 ABSTRACT
 INTRODUCTION
 METHODS
RESULTS
 DISCUSSION
 NOTES
 REFERENCES
 
Participants
Depression symptoms and diabetes self-management activities were measured in a cross-sectional survey of 276 type 1 diabetic patients treated at the University of Washington Diabetes Care Center (DCC) during both 1998 and 1999. Patients were paid $3 for the time and effort spent completing and returning the study questionnaires. The study was reviewed and approved by the University of Washington Institutional Review Board, and the principal findings, which describe the importance of attachment style to diabetes self-management and glycemic control, have been reported by Ciechanowski et al. (10). The subjects of the present study represented a convenience sample (n = 188, 68%) of the initial type 1 patients who were still being followed at the DCC as of September 2002. Psychometric testing of these subjects occurred in the interval extending from July 1 to December 31, 1999.

Measures
Symptoms of depression were measured with the revised version of the Hopkins Symptom Checklist-90 (SCL-90) (11). This self-report instrument was designed to measure psychologic symptom patterns in psychiatric and medical patients and has been validated in both populations. Each item is rated on a five-point distress scale (0–4) ranging from "not at all" at one pole to "extremely" at the other. The SCL-90 is scored and interpreted in terms of its nine primary dimensions or subscales, one of which assesses depression. The 20 items that comprise this subscale were used to assess the severity of depression symptoms (10,12).

Specific components of diabetes self-care were assessed with the Summary of Diabetes Self-Care Activities (SDSCA) (13). The SDSCA is a 12-item self-report questionnaire that measures levels of self-care behavior and the degree of adherence with physician-recommended activities. Data attesting to the reliability and validity of the SDSCA recently were summarized by Toobert and Glasgow (7,8). The present study used the SDSCA questions that assess diet amount, exercise, and adherence to glucose monitoring, domains with potential relevance to depression. Raw scores for each were converted to z scores and averaged to form a composite z score for the SDSCA. A higher score indicates greater attention to self-care. The SDSCA and the SCL-90, the independent variables in the mediational analysis, were obtained simultaneously.

Demographic and clinical data were determined from questionnaire responses, electronic medical records, and medical charts. The degree of hyperglycemia was assessed by using the HbA1value linked to the office visit during which insulin dose data were recorded. HbA1c measurement was performed with a Bayer DCA2000 glucometer, a model that is certified by the National Glycohemoglobin Standardization Program for its comparability to the reference methods established by the Diabetes Control and Complication Trial (14). Insulin dose (total number of units per day) for the office visit closest to the date of psychometric testing was recorded from the patient’s medical chart. The majority of visits occurred within 3 months of psychometric testing; no interval exceeded 6 months.

Statistical Analysis
Ordinary least-squares multiple regression analysis was used to determine the effect of depression scale score on HbA1c level, adjusting for weight and insulin dose. To further investigate the relationship between depression symptoms and HbA1c levels, subjects were subdivided into depressed and nondepressed subsets using the SCL-90 depression score. The base rate of major depression in patients with type 1 diabetes is approximately 10% (15); accordingly, the score representing the 90th percentile for the current sample was used as the threshold for establishing depression cases. Depressed subjects were further stratified by severity using the SCL-90 depression subscale scores to segregate the upper and lower quartile as having severe and mild depression symptoms, respectively, compared with the remainder (moderate symptoms). Analyses of covariance (ANCOVAs) were performed comparing A1C levels in depressed and nondepressed subjects and across severity subsets (within the depressed subject group) while controlling for between group differences in weight and insulin dose.

Mediational analysis was performed using the principles and procedures described by Baron and Kenny (16), as well as Kraemer (9) and Babyak (17), recognizing that the lack of temporal precedence information about the independent variables renders preliminary any inferences about causal mediation. Pearson’s r was used to evaluate univariate relationships among continuous variables. Correlation of the independent variables with each other and with the dependent variable was a prerequisite for proceeding with mediational analysis. The SDSCA score was then added to the original regression analysis to test the hypothesis that diabetes self-care behavior mediates the effect of depression symptoms on HbA1c level. Attenuation of the effect of depression symptoms by the addition of the SDSCA score would provide evidence that self-care behavior partially mediates this effect; elimination of depression from the model would provide evidence that the effect is completely mediated by self-care behavior.


   RESULTS
TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
DISCUSSION
 NOTES
 REFERENCES
 
Selected demographic, depression, and diabetes characteristics of the sample of 188 patients with type 1 diabetes are presented in Table 1. None of these was significantly different from the findings in the larger group of 276 patients. Raw scores on SDSCA subscale items are presented in Table 2. The ordinary least-squares regression demonstrated a significant effect of depression symptoms as a continuous variable on HbA1c level after controlling for the effects of weight and insulin dose (t = 3.6, p <.001). The parameter estimate of this effect was 0.53. When the subjects were stratified by depression caseness as defined, HbA1c levels were significantly higher in the depressed than in the nondepressed group (covariate-adjusted means ± standard error of mean [SEM] = 8.8% ± 0.3% vs. 7.6% ± 0.1%, F = 10.1, p <.0001) (Fig. 1). Scores on the SCL-90 depression subscale were 2.3 ± 0.4 in the depressed group compared with 0.6 ± 0.4 in the nondepressed group. HbA1c levels also varied in relation to severity of depression symptoms within the depressed group (p = .02 across subgroups). These findings corroborate previous observations demonstrating the association of depression with hyperglycemia (1).


View this table:
[in this window]
[in a new window]
  		TABLE 1. Clinical Characteristics of the Sample

 

View this table:
[in this window]
[in a new window]
  		TABLE 2. Raw Scores on Subscales of the Summary of Diabetes Self-Care Activities (SDSCA) Measure

 


View larger version (40K):
[in this window]
[in a new window]
  		Figure 1. Mean glycosylated hemoglobin (HbA1c) level in relation to depression status after adjusting for weight and total daily insulin dose. HbA1c levels were significantly higher in depressed compared with nondepressed subjects and showed a stepwise increase in relation to depression severity within the depressed subject group. Error bars represent standard error of mean.

 

Depression symptoms, SDSCA composite score, and HbA1c level were significantly correlated with one another (Table 3). When the SDSCA score was added to the ordinary least-squares regression analysis, the parameter estimate for the depression effect on HbA1c level was altered minimally (parameter estimate 0.50, t = 3.3, p = .001) and the SDSCA score had no significant effect within the model (p = .40). Thus, no evidence was obtained that diabetes self-care behavior as measured by the SDSCA mediates the relationship between depression symptom scores and HbA1c levels.


View this table:
[in this window]
[in a new window]
  		TABLE 3. Intercorrelation of Measures of Depression, Diabetes Self-Care, and Glycemic Control

 


   DISCUSSION
TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
NOTES
 REFERENCES
 
Morbidity from diabetes is a significant public health issue, accounting for more than one of every $10 spent for health care in the United States (18). Hyperglycemia is the most robust predictor of diabetes complications (14,19–22). Treatments that directly lower glucose reduce the risk of complications and comprise the cornerstone of diabetes management (14,20–22). Diabetes care also targets other risk factors for complications (eg, hypertension, hyperlipidemia) and factors that may oppose efforts to achieve glycemic control. Depression is considered one such factor and is included among the components of comprehensive care outlined in the American Diabetes Association’s clinical practice recommendation entitled Standards for Medical Care in Diabetes (23).

Clinically significant depression is present in approximately one in four patients with diabetes (type 1 or type 2) and is associated with hyperglycemia and with increased risk for diabetes complications (1,2,15,24). The mechanisms responsible for these effects presently are unclear. The most common explanation is that depression reduces adherence to medical care recommendations (25), a hypothesis supported by cross-sectional observations in diabetes and other medical illnesses (12,24,26–30). Adherence is recognized as an important contributor to diabetes control, particularly in type 1 diabetes, and also was correlated with lower HbA1c levels in our patient sample (31–33).

In the present study, we used a preliminary application of mediational analysis to help determine the role of diabetes self-care behaviors in depression-associated hyperglycemia. Consistent with this approach, we established that depression symptoms and diabetes self-care (the independent variables) correlated with each other and with HbA1c (the dependent variable). Using regression analysis, we found that depression symptoms predicted HbA1c level, an effect independent of weight and insulin dose. Adding diabetes self-care to the regression model, however, did not significantly alter the significant effect of depression. The findings were identical in post hoc analyses of the subset of subjects (n = 123) in whom body mass index information was available. We conclude that, although adherence to diabetes self-care may importantly influence metabolic control, diabetes self-care behavior did not mediate the additional hyperglycemia associated with depression.

Alternative theories are emerging that could explain the depression–hyperglycemia relationship, one being that depression induces insulin resistance (24). Insulin resistance is a hallmark feature of type 2 diabetes preceding overt hyperglycemia by a number of years, and factors that increase insulin resistance exacerbate hyperglycemia in any form of diabetes (34–36). A limited amount of information supports the association of depression with insulin resistance in nondiabetic individuals (37–42); some of these investigations were methodologically flawed by not controlling for confounding factors. Other potential mediators of the relationship involve the hypothalamic–pituitary–adrenal axis, the autonomic nervous system, and immunoinflammatory processes (43–45). Because of its broad association with inflammatory markers, depression may influence cellular modulation of the stress response, including effects on the transcriptional factor nuclear factor-{kappa}ß that regulates proinflammatory cytokines, adhesion molecules, and chemokines (46). There also is some evidence that insulin resistance decreases with depression treatment (41), but a shared precursor event leading to both depression and insulin resistance remains plausible. For example, Chiba et al. (47) found that specific tyrosine hydroxylase gene microsatellite polymorphisms were shared between nondepressed subjects with insulin resistance and depressed subjects. Such processes might make depression-associated hyperglycemia less responsive to depression treatment alone (25,48).

Our study has a number of strengths and some important limitations. Strengths include the facts that the sample of type 1 patients was relatively large (n = 188), constrained some factors that affect glycemic control (weight, insulin availability), and enabled precise measurement of other potentially confounding factors (diabetes treatment assessed by insulin dose). The study satisfied certain prerequisites for mediational analysis: 1) measures of the independent variables, depression symptoms, and diabetes self-care, correlated significantly with one another and with the dependent variable (HbA1c); 2) assessment of these variables was objective and blinded to assure independence of their errors of measurement; and 3) the independent variable had a significant effect on the dependent variable. The cross-sectional design of the study did not allow us to determine precisely the temporal relationships among the variables, a factor that would have been of greater relevance had the results suggested mediation, and no available measure perfectly reflects the spectrum of behaviors involved in diabetes self-care. In fact, adherence to the insulin regimen is measured only by proxy with the SDSCA yet is a key factor in glycemic control. Prospective or controlled treatment trials that incorporate behavioral monitoring (eg, activity diaries, insulin use) are needed to establish fully the causal pathways linking depression with poor metabolic control. Additionally, although the SCL-90 has been validated in medically ill populations, the measure is not as widely used as other self-report measures (eg, Beck Depression Inventory).

Depression has been associated with increases in HbA1c levels typically in the range of 0.5% to 1.0% (1). Although seemingly small, sustained elevations of this magnitude are clinically significant and accelerate the appearance of diabetes complications (14). Adherence to self-care recommendations is an essential aspect of the diabetes management plan, but additional targets for improving glycemic control appear relevant in depressed patients. Whether depression-associated hyperglycemia can be reversed with conventional depression treatment remains uncertain, the outcomes in part being confounded by direct hyperglycemic effects of some antidepressant medications (49). Likewise, until the mechanisms and directionality underlying the relationship between depression and hyperglycemia are fully understood, treatment remains empiric and targeted at reducing depression symptoms as if they impose hyperglycemic risk (23,50). Novel treatment approaches that have the capacity to improve both depression and glycemic control need exploration for optimizing outcomes in depressed diabetic patients.


   NOTES
TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 NOTES
REFERENCES
 
This work was supported in part by grants DK36452, DK53060, and DK59364 from the National Institutes of Health.

Received for publication July 14, 2004; revision received September 7, 2004.

DOI:10.1097/01.psy.0000155670.88919.ad


   REFERENCES
TOP
 ABSTRACT
 INTRODUCTION
 METHODS
 RESULTS
 DISCUSSION
 NOTES
 REFERENCES
 

  1. Lustman PJ, Anderson RJ, Freedland KE, de Groot M, Carney RM, Clause RE. Depression and poor glycemic control: a meta-analytic review of the literature. Diabetes Care 2000;23:434–42.[Medline]
  2. de Groot M, Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. Association of depression and diabetes complications: a meta-analysis. Psychosom Med 2001;63:619–30.[Abstract/Free Full Text]
  3. Clouse RE, Lustman PJ, Freedland KE, Griffith LS, McGill JB, Carney RM. Depression and coronary heart disease in women with diabetes. Psychosom Med 2003;65:376–83.[Abstract/Free Full Text]
  4. Forrest KYZ, Becker DJ, Kuller LH, Wolfson SK, Orchard TJ. Are predictors of coronary heart disease and lower-extremity arterial disease in type 1 diabetes the same? A prospective study. Atherosclerosis 2000;148:159–69.[CrossRef][Medline]
  5. Peyrot M, McMurry JF Jr, Kruger DF. A biopsychosocial model of glycemic control in diabetes: stress, coping and regimen adherence. J Health Soc Behav 1999;40:141–58.[CrossRef][Medline]
  6. Lustman PJ, Griffith LS, Clouse RE. Depression in adults with diabetes: results of a 5-year follow-up study. Diabetes Care 1988;11:605–12.[Abstract]
  7. Toobert DJ, Glascow RE. Assessing diabetes self-management: the summary of diabetes self-care activities questionnaire. In: Bradley C, ed. Handbook of Psychology and Diabetes. Berkshire, UK: Harwood Academic; 1994.
  8. Toobert DJ, Hampson SE, Glasgow RE. The summary of diabetes self-care activities measure: results from 7 studies and a revised scale. Diabetes Care 2000;23:943–50.[Abstract]
  9. Kraemer HC, Stice E, Kazdin A, Offord D, Kupfer D. How do risk factors work together? Mediators, moderators, and independent, overlapping, and proxy risk factors. Am J Psychiatry 2001;158:848–56.
  10. Ciechanowski PS, Hirsch IB, Katon WJ. Interpersonal predictors of HbA(1c) in patients with type 1 diabetes. Diabetes Care 2002;25:731–6.[Abstract/Free Full Text]
  11. Derogatis LR, Lipman RS, Rickels K, Uhlenhuth EH, Covi L. The Hopkins symptom checklist (HSCL): a self-report symptom inventory. Behav Sci 1974;19:1–15.[Medline]
  12. Ciechanowski PS, Katon WJ, Russo JE. Depression and diabetes: impact of depressive symptoms on adherence, function, and costs. Arch Intern Med 2000;160:3278–85.[Abstract/Free Full Text]
  13. Wysocki T. Impact of blood glucose monitoring on diabetic control: obstacles and interventions. J Behav Med 1989;12:183–205.[CrossRef][Medline]
  14. DCCT: The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977–85.[Abstract/Free Full Text]
  15. Anderson RJ, Freedland KE, Clouse RE, Lustman PJ. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. Diabetes Care 2001;24:1069–78.[Abstract/Free Full Text]
  16. Baron RM, Kenny DA. The moderator–mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol 1986;51:1173–82.[CrossRef][Medline]
  17. Babyak MA. What you see may not be what you get: a brief, nontechnical introduction to overfitting in regression-type models. Psychosom Med 2004;66:411–21.[Abstract/Free Full Text]
  18. Economic Costs of Diabetes in the US in 2002. Diabetes Care 2003;26:917–32.[Abstract/Free Full Text]
  19. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000;321:405–12.[Abstract/Free Full Text]
  20. Tests of Glycemia in Diabetes. Diabetes Care 2004;27:91S–993.
  21. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837–53.[CrossRef][Medline]
  22. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. N Engl J Med 2000;342:381–9.[Abstract/Free Full Text]
  23. Standards of medical care in diabetes. Diabetes Care 2004;27(suppl 1):S15–30.
  24. Lustman PJ, Clouse RE. Treatment of depression in diabetes: impact on mood and medical outcome. J Psychosom Res 2002;53:917–24.[CrossRef][Medline]
  25. Jackson JL, DeZee K, Berbano E. Can treating depression improve disease outcomes? Ann Intern Med 2004;1401054–6.
  26. DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000;160:2101–7.[Abstract/Free Full Text]
  27. Littlefield CH, Craven JL, Rodin GM, Daneman D, Murray MA, Rydall AC. Relationship of self-efficacy and bingeing to adherence to diabetes regimen among adolescents. Diabetes Care 1992;15:90–4.[Abstract]
  28. McGill JB, Lustman PJ, Griffith LS, Freedland KE, Gavard JA, Clouse RE. Relationship of depression to compliance with self-monitoring of blood glucose. Diabetes 1992;41:A84.
  29. Carney RM, Freedland KE, Eisen SA, Rich MW, Jaffe AS. Major depression and medication adherence in elderly patients with coronary artery disease. Health Psychol 1995;14:88–90.[CrossRef][Medline]
  30. Ziegelstein RC, Fauerbach JA, Stevens SS, Romanelli J, Richter DP, Bush DE. Patients with depression are less likely to follow recommendations to reduce cardiac risk during recovery from a myocardial infarction. Arch Intern Med 2000;160:1818–23.[Abstract/Free Full Text]
  31. Norris SL, Lau J, Smith SJ, Schmid CH, Engelgau MM. Self-management education for adults with type 2 diabetes: a meta-analysis of the effect on glycemic control. Diabetes Care 2002;25:1159–71.[Abstract/Free Full Text]
  32. Williams GC, McGregor HA, Zeldman A, Freedman ZR, Deci EL. Testing a self-determination theory process model for promoting glycemic control through diabetes self-management. Health Psychol 2004;23:58–66.[CrossRef][Medline]
  33. Norris SL, Engelgau MM, Narayan KM. Effectiveness of self-management training in type 2 diabetes: a systematic review of randomized controlled trials. Diabetes Care 2001;24:561–87.[Abstract/Free Full Text]
  34. Aronson D, Rayfield EJ. Diabetes and atherosclerosis. In: Topol EJ, ed. Comprehensive Cardiovascular Medicine. New York: Lippincott-Raven; 1998:185–208.
  35. Barrett-Connor EL, Cohn BA, Wingard DL, Edelstein SL. Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? JAMA 1991;265:627–31.[Abstract]
  36. Solymoss BC, Marcil M, Chaour M, Gilfix BM, Poitras AM, Campeau L. Fasting hyperinsulinism, insulin resistance syndrome, and coronary artery disease in men and women. Am J Cardiol 1995;76:1152–6.[CrossRef][Medline]
  37. McCarty MF. Enhancing central and peripheral insulin activity as a strategy for the treatment of endogenous depression—an adjuvant role for chromium picolinate? Med Hypotheses 1994;43:247–52.[CrossRef][Medline]
  38. Mueller PS, Heninger GR, McDonald RK. Insulin tolerance test in depression. Arch Gen Psychiatry 1969;21:587–94.[Medline]
  39. Wright JH, Jacisin JJ, Radin NS, Bell RA. Glucose metabolism in unipolar depression. Br J Psychiatry 1978;132:386–93.[Abstract/Free Full Text]
  40. Nathan RS, Sachar EJ, Asnis GM. Relative insulin insensitivity and cortisol secretion in depressed patients. Psychiatry Res 1981;4:291–300.[CrossRef][Medline]
  41. Okamura F, Tashiro A, Utumi A, Imai T, Suchi T, Tamura D, Sato Y, Suzuki S, Hongo M. Insulin resistance in patients with depression and its changes during the clinical course of depression: minimal model analysis. Metabolism 2000;49:1255–60.[CrossRef][Medline]
  42. Winokur A, Maislin G, Phillips JL, Amsterdam JD. Insulin resistance after oral glucose tolerance testing in patients with major depression. Am J Psychiatry 1988;145:325–30.[Abstract/Free Full Text]
  43. Musselman DL, Betan E, Larsen H, Phillips LS. Relationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment. Biol Psychiatry 2003;54:317–29.[CrossRef][Medline]
  44. Ramasubbu R. Insulin resistance: a metabolic link between depressive disorder and atherosclerotic vascular diseases. Med Hypotheses 2002;59:537–51.[CrossRef][Medline]
  45. Boden G, Hoeldtke RD. Nerves, fat, and insulin resistance. N Engl J Med 2003;349:1966–7.[Free Full Text]
  46. Hirsch IB. Effect of insulin therapy on nonglycemic variables during acute illness. Endocr Pract 2004;10(suppl 2):63–70.
  47. Chiba M, Suzuki S, Hinokio Y, Hirai M, Satoh Y, Tashiro A, Utsumi A, Awata T, Hongo M, Toyota T. Tyrosine hydroxylase gene microsatellite polymorphism associated with insulin resistance in depressive disorder. Metabolism 2000;49:1145–9.[CrossRef][Medline]
  48. Williams JW Jr, Katon W, Lin EH, Noel PH, Worchel J, Cornell J, Harpole L, Fultz BA, Hunkeler E, Mika VS, Unutzer J, IMPACT Investigators. The effectiveness of depression care management on diabetes-related outcomes in older patients. Ann Intern Med 2004;140:1015–24.[Abstract/Free Full Text]
  49. Lustman PJ, Griffith LS, Clouse RE, Freedland KE, Eisen SA, Rubin EH, Carney RM, McGill JB. Effects of nortriptyline on depression and glycemic control in diabetes: results of a double-blind, placebo-controlled trial. Psychosom Med 1997;59:241–50.[Abstract/Free Full Text]
  50. Lustman PJ, Clouse RE. Depression: a potentially modifiable risk factor for diabetes and its complications. Diabetes Spectrum; in press.



This article has been cited by other articles:


Home page
 Diabetes CareHome page
M. S. Roy, M. Affouf, and A. Roy
Six-Year Incidence of Proteinuria in Type 1 Diabetic African Americans
Diabetes Care, July 1, 2007; 30(7): 1807 - 1812.
[Abstract] [Full Text] [PDF]

Home page
 Psychosom. Med.Home page
M. S. Roy, A. Roy, and M. Affouf
Depression is a Risk Factor for Poor Glycemic Control and Retinopathy in African-Americans With Type 1 Diabetes
Psychosom Med, July 1, 2007; 69(6): 537 - 542.
[Abstract] [Full Text] [PDF]

Home page
 Diabetes CareHome page
P. J. Lustman, M. M. Williams, G. S. Sayuk, B. D. Nix, and R. E. Clouse
Factors Influencing Glycemic Control in Type 2 Diabetes During Acute- and Maintenance-Phase Treatment of Major Depressive Disorder With Bupropion
Diabetes Care, March 1, 2007; 30(3): 459 - 466.
[Abstract] [Full Text] [PDF]

Home page
 Clin. DiabetesHome page
M. M. Williams, R. E. Clouse, and P. J. Lustman
Treating Depression to Prevent Diabetes and Its Complications: Understanding Depression as a Medical Risk Factor
Clin. Diabetes, April 1, 2006; 24(2): 79 - 86.
[Abstract] [Full Text] [PDF]

This Article
Right arrow Abstract Freely available
Right arrow Figures Only
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lustman, P. J.
Right arrow Articles by Freedland, K. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lustman, P. J.
Right arrow Articles by Freedland, K. E.
Related Collections
Right arrow Endocrinology
Right arrow Depression
Right arrow Diabetes

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS